Detalhe da pesquisa
1.
Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung Cancer.
Int J Mol Sci;
24(2)2023 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36674513
2.
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
Cancer Immunol Immunother;
71(12): 2881-2898, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35460379
3.
Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study.
PLoS Genet;
14(2): e1007194, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29447163
4.
Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer.
Int J Mol Sci;
22(16)2021 Aug 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34445452
5.
Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes.
Int J Cancer;
146(8): 2147-2155, 2020 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31265121
6.
An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+ T Cells is Dependent on IL-10 and Independent of BRAFV600E Mutation in Melanoma Cell Lines.
Immunol Invest;
49(7): 744-757, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32799717
7.
Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.
Blood;
130(13): 1585-1596, 2017 09 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28811306
8.
Nature of tumour rejection antigens in ovarian cancer.
Immunology;
155(2): 202-210, 2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29772069
9.
Correction to: Tcf1 protects antitumor TCRengineered CD8+ Tcells from GzmB mediated selfdestruction.
Cancer Immunol Immunother;
71(12): 2899, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35666273
10.
Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity.
Nucleic Acids Res;
43(15): 7330-48, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26117541
11.
Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.
Carcinogenesis;
35(2): 262-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24104552
12.
Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
Carcinogenesis;
34(2): 248-56, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23087083
13.
Loss of mammal-specific tectorial membrane component carcinoembryonic antigen cell adhesion molecule 16 (CEACAM16) leads to hearing impairment at low and high frequencies.
J Biol Chem;
287(26): 21584-98, 2012 Jun 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22544735
14.
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.
Nucleic Acids Res;
39(6): 2045-56, 2011 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21088000
15.
Reprogramming the tumor microenvironment leverages CD8+ T cell responses to a shared tumor/self antigen in ovarian cancer.
Mol Ther Oncolytics;
28: 230-248, 2023 Mar 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36875325
16.
Innate TCRß-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials.
Sci Adv;
9(49): eadj6174, 2023 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38055824
17.
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Sci Transl Med;
14(636): eabg8402, 2022 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35294258
18.
IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation.
Front Immunol;
12: 678999, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34025677
19.
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
J Immunother Cancer;
9(10)2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34607898
20.
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
J Immunother Cancer;
9(2)2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33589522